Center of Excellence for Bladder Cancer
At Mount Sinai’s Center of Excellence for Bladder Cancer, we focus all our resources on you, our patient, and your family. We are here to help from diagnosis through treatment to follow-up care.
Mount Sinai’s Center of Excellence for Bladder Cancer - one of a number of Centers of Excellence at The Tisch Cancer Institute - provides multi-disciplinary, cutting-edge, and highly personalized care to patients with all forms of bladder cancer. The team of bladder cancer experts at Mount Sinai has played a major role in the development of important recent advances in bladder cancer care including robotic surgery and immunotherapy.
Bladder cancer is one of the most common cancers affecting people over age 55. When diagnosed early, it is highly treatable. When diagnosed at more advanced stages, multi-disciplinary care is critical to achieve the best outcomes. That’s why it is so important to see a team of doctors who specifically focus on the care of patients with bladder cancer.
Why Mount Sinai
Dr. Galsky leads groundbreaking immunotherapy research that is transforming care for patients with aggressive bladder cancer. He is Director of Genitourinary Medical Oncology and Medical Director of Novel Therapeutics at The Tisch Cancer Institute. Dr. Galsky is Professor of Medicine, Division of Hematology and Medical Oncology, and Professor of Urology at the Icahn School of Medicine at Mount Sinai.
Dr. Wiklund pioneered robot-assisted cystectomy and has performed more than 3,000 robotic operations. At Mount Sinai Dr. Wiklund leads one of the most robust robotic cystectomy programs in the world. He plays an important role with the American Urological Association, as well as the European Urology Robotic Section of the European Association of Urology. Dr. Wiklund is Professor of Urology at the Icahn School of Medicine at Mount Sinai.